AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8279244 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil 20 micrograms.kg‐1 + lidocaine 1 mg.kg‐1
Number of subjects: 45
Study 3060461 — intervention group
Group type: EXPERIMENTAL
Intervention: Roxithromycin
Number of subjects: 0
Study 3060461 — intervention group
Group type: COMPARATOR
Intervention: Erythromycin ethylsuccinate
Number of subjects: 0
Study 31119938 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonspherical biosynthetic bubbles
Number of subjects: 0
Study 28566854 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyrax RME appliance
Number of subjects: 12
Study 28566854 — intervention group
Group type: COMPARATOR
Intervention: Fan-type RME appliance
Number of subjects: 12
Study 28566854 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 12
Study 28566854 — intervention group
Group type: COMPARATOR
Intervention: Fan-type RME
Number of subjects: 12
Study 28566854 — intervention group
Group type: COMPARATOR
Intervention: Hyrax
Number of subjects: 12
Study 26147383 — intervention group
Group type: EXPERIMENTAL
Intervention: B-vitamin supplementation (500 μg vitamin B12 and 400 μg folic acid)
Number of subjects: 2919
Study 26147383 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2919
Study 23341184 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonojet disposable tonometer
Number of subjects: 293
Study 23341184 — intervention group
Group type: COMPARATOR
Intervention: Goldmann tonometer
Number of subjects: 293
Study 23341184 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonojet disposable tonometer in eyes with ocular hypertension/glaucoma
Number of subjects: 293
Study 23341184 — intervention group
Group type: COMPARATOR
Intervention: Goldmann tonometer in eyes with ocular hypertension/glaucoma
Number of subjects: 293
Study 22021297 — intervention group
Group type: EXPERIMENTAL
Intervention: AMIGAS intervention (4 sessions)
Number of subjects: 252
Study 22021297 — intervention group
Group type: COMPARATOR
Intervention: 1-session health intervention
Number of subjects: 252
Study 18430451 — intervention group
Group type: EXPERIMENTAL
Intervention: Angles in isosceles triangles
Number of subjects: 0
Study 18430451 — intervention group
Group type: COMPARATOR
Intervention: Angles in scalene triangles
Number of subjects: 0
Study 19912283 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical diltiazem (DTZ) ointment (2%; n = 16)
Number of subjects: 33
Study 19912283 — intervention group
Group type: COMPARATOR
Intervention: Placebo ointment (n = 17)
Number of subjects: 33
Study 16145097 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal metronidazole
Number of subjects: 119
Study 16145097 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal clindamycin
Number of subjects: 119
Study 16145097 — intervention group
Group type: COMPARATOR
Intervention: Both therapies (metronidazole and clindamycin)
Number of subjects: 119
Study 11966862 — intervention group
Group type: EXPERIMENTAL
Intervention: Almotriptan 12.5 mg
Number of subjects: 1321
Study 11966862 — intervention group
Group type: EXPERIMENTAL
Intervention: Almotriptan 6.25 mg
Number of subjects: 1321
Study 11966862 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1321
Study 9688625 — intervention group
Group type: COMPARATOR
Intervention: Baseline conditions (normal nighttime sleep)
Number of subjects: 15
Study 9688625 — intervention group
Group type: EXPERIMENTAL
Intervention: Day 1 (after sleep deprivation)
Number of subjects: 15
Study 9688625 — intervention group
Group type: EXPERIMENTAL
Intervention: Day 2 (after sleep shift)
Number of subjects: 15
Study 8136641 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation training by audio tapes
Number of subjects: 67
Study 8136641 — intervention group
Group type: EXPERIMENTAL
Intervention: Live relaxation training by nurses
Number of subjects: 67
Study 8136641 — intervention group
Group type: COMPARATOR
Intervention: No relaxation training (Control)
Number of subjects: 67
Study 2909831 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspartame (APM) at 10 mg APM/kg body weight per serving, ingested in three successive 12-oz servings at 2-hour intervals (study 1)
Number of subjects: 12
Study 2909831 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspartame (APM) at 30 mg APM/kg body weight as a single bolus (study 2)
Number of subjects: 12
Study 2909831 — intervention group
Group type: COMPARATOR
Intervention: Control group (beverage not sweetened) in study 1
Number of subjects: 12
Study 60623 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh-frozen plasma (F.F.P) 12 ml/kg body-weight
Number of subjects: 30
Study 60623 — intervention group
Group type: EXPERIMENTAL
Intervention: Prothrombin complex concentrates
Number of subjects: 30
Study 60623 — intervention group
Group type: EXPERIMENTAL
Intervention: Factor-VII concentrate
Number of subjects: 30
Study 60623 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined administration of lower dose of F.F.P. (8 ml/kg body-weight) and both concentrates (12 units/ml)
Number of subjects: 30
Study 30594760 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 sessions of individual CBT adjunctive to treatment as usual (TAU)
Number of subjects: 80
Study 30594760 — intervention group
Group type: COMPARATOR
Intervention: TAU alone
Number of subjects: 80
Study 30541592 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise program
Number of subjects: 0
Study 30541592 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 0
Study 26920910 — intervention group
Group type: EXPERIMENTAL
Intervention: C. caudatus treated group (U)
Number of subjects: 100
Study 26920910 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 100
Study 24553532 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI) counseling
Number of subjects: 200
Study 24553532 — intervention group
Group type: COMPARATOR
Intervention: No discussion (Control)
Number of subjects: 200
Study 24553532 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI)
Number of subjects: 200
Study 22431971 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD) with an amino acid beverage lacking tryptophan
Number of subjects: 40
Study 22431971 — intervention group
Group type: COMPARATOR
Intervention: TRP-balanced amino acid beverage (BAL)
Number of subjects: 40
Study 19453695 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter arterial chemoembolization (TACE) with lipiodol, doxorubicin and cisplatin
Number of subjects: 100
Study 19453695 — intervention group
Group type: COMPARATOR
Intervention: Systemic doxorubicin
Number of subjects: 100
Study 19453695 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter arterial chemoembolization (TACE)
Number of subjects: 100
Study 17484866 — intervention group
Group type: EXPERIMENTAL
Intervention: Isobaric distention to unpleasant or painful sensation
Number of subjects: 13
Study 17484866 — intervention group
Group type: COMPARATOR
Intervention: Sham distention
Number of subjects: 13
Study 17484866 — intervention group
Group type: COMPARATOR
Intervention: No distention
Number of subjects: 13
Study 15465636 — intervention group
Group type: EXPERIMENTAL
Intervention: Older subjects (over 60 years) during saccadic task
Number of subjects: 53
Study 15465636 — intervention group
Group type: EXPERIMENTAL
Intervention: Older subjects (over 60 years) during antisaccadic task
Number of subjects: 53
Study 15465636 — intervention group
Group type: EXPERIMENTAL
Intervention: Older subjects (over 60 years) during smooth pursuit at 20 degrees/s
Number of subjects: 53
Study 15465636 — intervention group
Group type: EXPERIMENTAL
Intervention: Older subjects (over 60 years) during smooth pursuit at 40 degrees/s
Number of subjects: 53
Study 15465636 — intervention group
Group type: EXPERIMENTAL
Intervention: Older subjects (over 60 years) compared to middle-aged subjects (41-60 years)
Number of subjects: 53
Study 15465636 — intervention group
Group type: EXPERIMENTAL
Intervention: Head movement gain during gaze shifts
Number of subjects: 53
Study 11430619 — intervention group
Group type: EXPERIMENTAL
Intervention: Foldable intraocular lens (IOL)
Number of subjects: 82
Study 11430619 — intervention group
Group type: COMPARATOR
Intervention: Rigid intraocular lens (IOL)
Number of subjects: 82
Study 11430619 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Rigid IOL and Foldable IOL)
Number of subjects: 82
Study 9855069 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nicotine
Number of subjects: 30
Study 9855069 — intervention group
Group type: COMPARATOR
Intervention: Prednisone
Number of subjects: 30
Study 7843980 — intervention group
Group type: EXPERIMENTAL
Intervention: Stages of change in dietary fat consumption
Number of subjects: 17121
Study 7843980 — intervention group
Group type: EXPERIMENTAL
Intervention: Stages of change in dietary fiber consumption
Number of subjects: 17121
Study 7843980 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage of change
Number of subjects: 17121
Study 2645561 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac sodium 50 mg (q.i.d.)
Number of subjects: 99
Study 2645561 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefopam 60 mg (q.i.d.)
Number of subjects: 99
Study 2645561 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) 640 mg + codeine 40 mg (q.i.d.)
Number of subjects: 99
Study 29482213 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 290
Study 29482213 — intervention group
Group type: EXPERIMENTAL
Intervention: Education (EDU)
Number of subjects: 290
Study 29482213 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 290
Study 28522078 — intervention group
Group type: EXPERIMENTAL
Intervention: Positional therapy (PT)
Number of subjects: 99
Study 28522078 — intervention group
Group type: COMPARATOR
Intervention: Oral appliance therapy (OAT)
Number of subjects: 99
Study 28522078 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep position trainer (SPT)
Number of subjects: 99
Study 26275236 — intervention group
Group type: EXPERIMENTAL
Intervention: cathodal transcranial direct current stimulation (c‐tDCS) of M1, S1 and DLPFC at 0.3 mA for 20 min
Number of subjects: 0
Study 26275236 — intervention group
Group type: EXPERIMENTAL
Intervention: cathodal transcranial direct current stimulation (c‐tDCS) of S1, M1 and DLPFC
Number of subjects: 0
Study 26275236 — intervention group
Group type: EXPERIMENTAL
Intervention: cathodal transcranial direct current stimulation (c‐tDCS) of M1, S1 and DLPFC
Number of subjects: 0
Study 23039931 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS treatment (n = 13)
Number of subjects: 27
Study 23039931 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS treatment (n = 12)
Number of subjects: 27
Study 20363906 — intervention group
Group type: EXPERIMENTAL
Intervention: Outgroup critics with internal attributions
Number of subjects: 0
Study 20363906 — intervention group
Group type: COMPARATOR
Intervention: Outgroup critics with external attributions
Number of subjects: 0
Study 20363906 — intervention group
Group type: COMPARATOR
Intervention: Ingroup critics
Number of subjects: 0
Study 20363906 — intervention group
Group type: EXPERIMENTAL
Intervention: Outgroup criticism with an outgroup audience
Number of subjects: 0
Study 20363906 — intervention group
Group type: EXPERIMENTAL
Intervention: Concerns about ingroup's image
Number of subjects: 0
Study 19241895 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine plus cisplatin (GC)
Number of subjects: 83
Study 19241895 — intervention group
Group type: COMPARATOR
Intervention: Vinorelbine plus cisplatin (VC)
Number of subjects: 83
Study 16352625 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.9% saline + 2.5% dextrose (NS)
Number of subjects: 102
Study 16352625 — intervention group
Group type: COMPARATOR
Intervention: 0.45% saline + 2.5% dextrose (N/2)
Number of subjects: 102
Study 11800219 — intervention group
Group type: EXPERIMENTAL
Intervention: Intake appointments scheduled 1 day later
Number of subjects: 116
Study 11800219 — intervention group
Group type: COMPARATOR
Intervention: Intake appointments scheduled 3 days later
Number of subjects: 116
Study 11800219 — intervention group
Group type: COMPARATOR
Intervention: Intake appointments scheduled 7 days later
Number of subjects: 116
Study 10909473 — intervention group
Group type: EXPERIMENTAL
Intervention: IDDM patients (19 patients)
Number of subjects: 35
Study 10909473 — intervention group
Group type: EXPERIMENTAL
Intervention: NIDDM patients (16 patients)
Number of subjects: 35
Study 10909473 — intervention group
Group type: COMPARATOR
Intervention: Control groups (matched by age and gender)
Number of subjects: 35
Study 8625129 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary beta-glucuronidase activity
Number of subjects: 146
Study 2286487 — intervention group
Group type: EXPERIMENTAL
Intervention: Percussive vibratory massage for 4 min followed by 1 min of rest
Number of subjects: 12
Study 2286487 — intervention group
Group type: COMPARATOR
Intervention: Control condition with 5 min rest between series of contractions
Number of subjects: 12
Study 7208897 — intervention group
Group type: EXPERIMENTAL
Intervention: Mammography screening
Number of subjects: 0
Study 7208897 — intervention group
Group type: COMPARATOR
Intervention: Randomized projects
Number of subjects: 0
Study 31759645 — intervention group
Group type: EXPERIMENTAL
Intervention: General public's risk perceptions from environmental exposures
Number of subjects: 338
Study 31759645 — intervention group
Group type: COMPARATOR
Intervention: Expert evaluations of risk associated with environmental exposures
Number of subjects: 338
Study 31759645 — intervention group
Group type: EXPERIMENTAL
Intervention: Explanatory models of risk perceptions
Number of subjects: 338
Study 28863074 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO (22.5 g) alone
Number of subjects: 27
Study 28863074 — intervention group
Group type: EXPERIMENTAL
Intervention: Pro-CHO (CHO (15 g) + whey protein (10 g))
Number of subjects: 27
Study 27246662 — intervention group
Group type: EXPERIMENTAL
Intervention: Transducer and needle alignment in a sagittal plane, perpendicular to the shoulders
Number of subjects: 28
Study 27246662 — intervention group
Group type: COMPARATOR
Intervention: Transducer and needle alignment in a coronal plane, parallel to the shoulders
Number of subjects: 28
Study 25680925 — intervention group
Group type: EXPERIMENTAL
Intervention: rhC1INH (50 IU/kg)
Number of subjects: 44
Study 23593639 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental setup for fixing microtensile sticks
Number of subjects: 12
Study 23593639 — intervention group
Group type: COMPARATOR
Intervention: Flat Ciucchi's jig
Number of subjects: 12
Study 20939474 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flexion prostheses
Number of subjects: 144
Study 20939474 — intervention group
Group type: COMPARATOR
Intervention: Standard cruciate-stabling prostheses
Number of subjects: 144
Study 18719788 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine group (n=13): infusion of 1 microg/kg over 10 minutes and maintenance dose of 0.5 microg/kg/h as an adjuvant to inhaled isoflurane anesthesia
Number of subjects: 26
Study 18719788 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=13): normal saline infusion at a similar rate and volume of the dexmedetomidine infusion
Number of subjects: 26
Study 17027362 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg mifepristone (group I)
Number of subjects: 115
Study 17027362 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 microg misoprostol (group II)
Number of subjects: 115
Study 14623704 — intervention group
Group type: EXPERIMENTAL
Intervention: 15% azelaic acid gel
Number of subjects: 251
Study 14623704 — intervention group
Group type: COMPARATOR
Intervention: 0.75% metronidazole gel
Number of subjects: 251
Study 11078311 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat meal (900 calories, 50 g of fat)
Number of subjects: 15
Study 11078311 — intervention group
Group type: COMPARATOR
Intervention: Low-fat meal (900 calories, 4 g of fat)
Number of subjects: 15
Study 11078311 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat meal
Number of subjects: 15
Study 11078311 — intervention group
Group type: COMPARATOR
Intervention: Low-fat meal
Number of subjects: 15
Study 9378463 — intervention group
Group type: EXPERIMENTAL
Intervention: GH treatment
Number of subjects: 16
Study 8271174 — intervention group
Group type: EXPERIMENTAL
Intervention: PMMA IOLs (AMO PC58)
Number of subjects: 43
Study 8271174 — intervention group
Group type: COMPARATOR
Intervention: Silicone IOLs (AMO SI19, Adatomed 90D)
Number of subjects: 43
Study 3623739 — intervention group
Group type: EXPERIMENTAL
Intervention: Euphyllin retard
Number of subjects: 18
Study 3623739 — intervention group
Group type: COMPARATOR
Intervention: PulmiDur
Number of subjects: 18
Study 30420421 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE inhibitor monotherapy
Number of subjects: 1243
Study 30420421 — intervention group
Group type: EXPERIMENTAL
Intervention: ARB monotherapy
Number of subjects: 1243
Study 30420421 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 1243
Study 30420421 — intervention group
Group type: COMPARATOR
Intervention: ACE inhibitor
Number of subjects: 1243
Study 30420421 — intervention group
Group type: COMPARATOR
Intervention: ARB
Number of subjects: 1243
Study 30420421 — intervention group
Group type: COMPARATOR
Intervention: ACE inhibitor or ARB monotherapy or combination therapy
Number of subjects: 1243
Study 27593617 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot juice (140 ml daily, containing approximately 10 mmol of nitrate)
Number of subjects: 40
Study 27593617 — intervention group
Group type: COMPARATOR
Intervention: Control (blackcurrant cordial with negligible nitrate content)
Number of subjects: 40
Study 27593617 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot juice
Number of subjects: 40
Study 27593617 — intervention group
Group type: COMPARATOR
Intervention: Control (blackcurrant cordial)
Number of subjects: 40
Study 25014057 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (5 mg/day)
Number of subjects: 42
Study 25014057 — intervention group
Group type: COMPARATOR
Intervention: Losartan (100 mg/day)
Number of subjects: 42
Study 22193531 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (10 mg/day to 80 mg/day over 12 weeks)
Number of subjects: 37
Study 22193531 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 21105275 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 0
Study 21105275 — intervention group
Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 0
Study 21105275 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 0
Study 18197096 — intervention group
Group type: EXPERIMENTAL
Intervention: Parecoxib 40 mg/dose
Number of subjects: 120
Study 18197096 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 16180596 — intervention group
Group type: EXPERIMENTAL
Intervention: MOVE curriculum (experimental group, n=32)
Number of subjects: 44
Study 16180596 — intervention group
Group type: COMPARATOR
Intervention: Regular programme (control group, n=12)
Number of subjects: 44
Study 12204020 — intervention group
Group type: EXPERIMENTAL
Intervention: Mammography screening
Number of subjects: 154
Study 12204020 — intervention group
Group type: EXPERIMENTAL
Intervention: Mammography screening in women younger than 50 years
Number of subjects: 154
Study 12204020 — intervention group
Group type: COMPARATOR
Intervention: Clinical breast examination and breast self-examination
Number of subjects: 154
Study 9836061 — intervention group
Group type: EXPERIMENTAL
Intervention: PTSD subjects (16)
Number of subjects: 37
Study 9836061 — intervention group
Group type: COMPARATOR
Intervention: Combat controls (9)
Number of subjects: 37
Study 9836061 — intervention group
Group type: COMPARATOR
Intervention: Noncombat subjects (12)
Number of subjects: 37
Study 8137520 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan (6 mg, subcutaneous injection)
Number of subjects: 14
Study 8137520 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 2573377 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg tertatolol (T)
Number of subjects: 61
Study 2573377 — intervention group
Group type: COMPARATOR
Intervention: 100 mg atenolol (A)
Number of subjects: 61
Study 1053694 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined modality therapy (chemotherapy and irradiation)
Number of subjects: 0
Study 6928417 — intervention group
Group type: EXPERIMENTAL
Intervention: Alkaline sodium fluoride dentifrice
Number of subjects: 0
Study 6928417 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral sodium fluoride dentifrice
Number of subjects: 0
Study 6928417 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31481475 — intervention group
Group type: EXPERIMENTAL
Intervention: End-of-life care integrated into clinical care when a life-limiting prognosis was articulated.
Number of subjects: 15
Study 31481475 — intervention group
Group type: EXPERIMENTAL
Intervention: Informal care plans developed gradually without discussing with patients.
Number of subjects: 15
Study 31481475 — intervention group
Group type: EXPERIMENTAL
Intervention: GPs' provision of end-of-life care influenced by patient traits and GP characteristics.
Number of subjects: 15
Study 28693427 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote pharmacist-led intervention
Number of subjects: 461
Study 28693427 — intervention group
Group type: COMPARATOR
Intervention: Control sites
Number of subjects: 461
Study 28693427 — intervention group
Group type: EXPERIMENTAL
Intervention: Both intervention and control sites
Number of subjects: 461
Study 25259559 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper limb (UL) training
Number of subjects: 46
Study 24907946 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasogastric decompression postoperatively
Number of subjects: 115
Study 24907946 — intervention group
Group type: COMPARATOR
Intervention: No nasogastric decompression postoperatively
Number of subjects: 115
Study 22428494 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg of ketamine (Group K1)
Number of subjects: 45
Study 22428494 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg of ketamine (Group K2)
Number of subjects: 45
Study 22428494 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (Group N)
Number of subjects: 45
Study 19817264 — intervention group
Group type: EXPERIMENTAL
Intervention: Saccharomyces boulardii + metronidazole
Number of subjects: 85
Study 19817264 — intervention group
Group type: COMPARATOR
Intervention: Metronidazole
Number of subjects: 85
Study 17143189 — intervention group
Group type: EXPERIMENTAL
Intervention: mibefradil 100 mg daily
Number of subjects: 14